HAVCR2 and hepatocellular carcinoma: Studies had found that HAVCR2 was highly expressed in NK cells in TME, and hepatocellular carcinoma cells could lead to dysfunction of NK cell population by inhibiting PI3K/Akt/mTORC1 signaling pathway mediated by HAVCR2 (34).